Antimicrobial Drugs: Principles, Targets, and Drug Resistance

Antimicrobial Drugs

I. Key Terms

Antimicrobial drugs are chemical agents used to kill or inhibit the growth of microorganisms. Understanding their properties and mechanisms is essential for effective treatment and prevention of microbial diseases.

• Selective toxicity: The ability of a drug to target harmful microbes without damaging the host.

• Synthetic drugs: Chemically manufactured drugs, not derived from natural sources.

• Antibiotics: Substances produced by microorganisms that inhibit or kill other microbes.

• Broad Spectrum Antibiotic: Effective against a wide range of microorganisms.

• Narrow Spectrum Antibiotic: Effective against a specific group or species of microorganisms.

II. What Makes a Good Drug?

Several properties determine the clinical usefulness of an antimicrobial drug.

• High selective toxicity: Targets microbes with minimal harm to host cells.

• Low hypersensitivity: Minimizes allergic reactions in patients.

• Ability to penetrate body tissues: Reaches infection sites effectively.

• Microbes should not readily develop resistance: Reduces the risk of treatment failure.

• Low cost: Affordable for widespread use.

• Easy administration: Simple dosing and delivery methods.

• Tastes good: Improves patient compliance.

III. Targets of Antimicrobial Drugs

Antimicrobial drugs act on specific structures or processes in microbial cells. The evolutionary distance between prokaryotic and eukaryotic cells allows for selective targeting.

A. Bacterial Targets

Target	Example Drugs
Cell wall	Penicillin, Bacitracin
Ribosome	Streptomycin, Tetracycline
Nucleic acid synthesis	Rifampin
Enzymes	Sulfa drugs
Plasma membrane	Polymyxin B, Nystatin

• Cell wall synthesis inhibitors (e.g., penicillin) are highly selective because human cells lack cell walls.

• Ribosome inhibitors exploit differences between prokaryotic (70S) and eukaryotic (80S) ribosomes.

• Nucleic acid synthesis inhibitors (e.g., rifampin) block DNA/RNA production in bacteria.

• Enzyme inhibitors (e.g., sulfa drugs) block essential metabolic pathways.

• Plasma membrane disruptors (e.g., polymyxin B) damage bacterial membranes.

Additional info: Fungi, protozoans, and helminths have 80S ribosomes like eukaryotes, making selective toxicity more challenging. Viruses are even harder to target due to their reliance on host cell machinery.

IV. Drug Resistance

Drug resistance arises when microorganisms evolve mechanisms to withstand antimicrobial agents. This is a major challenge in clinical microbiology and public health.

• Selection pressure: Widespread use of antibiotics selects for resistant strains.

• Population dynamics: In the absence of antibiotics, resistance may be disadvantageous; in their presence, resistant strains thrive.

• Transmission: Resistant genes can spread through populations via horizontal gene transfer (e.g., conjugation).

• Clinical impact: Resistance leads to treatment failure and increased morbidity/mortality.

Factors contributing to resistance:

• Overuse and misuse of antibiotics (e.g., prescribing for viral infections).

• Incomplete courses of treatment.

• Use of antibiotics in agriculture and animal husbandry.

Examples of resistance:

• MRSA (Methicillin-resistant Staphylococcus aureus)

• MDR-TB (Multi-drug resistant Mycobacterium tuberculosis)

• VRE (Vancomycin-resistant Enterococcus)

Strategies to combat resistance:

• Development of new drugs and drug combinations.

• Prudent use of existing antibiotics.

• Surveillance and infection control measures.

Additional info: Combination therapy (using multiple drugs) can reduce the likelihood of resistance. Examples include the use of isoniazid and rifampin for TB, or AZT and protease inhibitors for HIV.

V. Summary Table: Major Antimicrobial Drugs and Their Targets

Drug Class	Target	Example
Beta-lactams	Cell wall synthesis	Penicillin
Aminoglycosides	Protein synthesis (ribosome)	Streptomycin
Tetracyclines	Protein synthesis (ribosome)	Tetracycline
Polymyxins	Plasma membrane	Polymyxin B
Sulfonamides	Enzyme inhibition	Sulfa drugs
Rifamycins	Nucleic acid synthesis	Rifampin

VI. Key Equations and Concepts

• Minimum Inhibitory Concentration (MIC): The lowest concentration of a drug that inhibits visible growth of a microorganism.

• Therapeutic Index (TI): Ratio of toxic dose to therapeutic dose. Higher TI indicates greater safety.

$\text{Therapeutic Index} = \frac{\text{Toxic Dose}}{\text{Therapeutic Dose}}$

VII. Clinical Applications

• Antimicrobial drugs are used to treat bacterial, fungal, and some protozoal infections.

• Selection of appropriate drug depends on pathogen, site of infection, and resistance patterns.

• Combination therapy may be necessary for resistant infections.

Example: Treatment of tuberculosis often requires a combination of isoniazid, rifampin, and ethambutol to prevent resistance and ensure efficacy.